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It  is  well  established  that  T  cells  play  an  important  regulatory  role  on  B-cell 
production  of antibody  (1). The  functions  ascribed  to  T  cells  include  help  (2), 
amplification  (3), and suppression (4, 5) of B cell clones.  Over the past several years 
much data have accumulated that  indicate that  the interactions between lymphoid 
cells are mediated by several regulatory components other than just antigen.  These 
include  antibody  feedback  (6),  regulation  by  cell  surface  and  soluble  molecules 
encoded, in part, by the major histocompatibility complex (7-9), and, more recently, 
interactions mediated by idiotypie determinants  (10,  11). Evidence for this network 
of interactions  that  is  mediated  by idiotypic determinants  has  gathered  strength, 
particularly by the data that indicate that both T  and B cells bear similar receptors 
for antigen as defined by anti-idiotypic antibody (12-15). Recent data have demon- 
strated  restrictions  between  subpopulations  of T-helper  and  B-cell  clones,  which 
appear to be governed, in part,  by idiotypic (Id) t determinants  located on antigen 
receptors (16,  17). So far these restrictions have not been reported between antigen- 
induced T-suppressor cells and responding B lymphocytes in the absence of exogenous 
Id antisera introduced into the system. To approach such a study, a model system in 
which specific probes, such as Id markers, is needed to follow the expression of certain 
B-cell clones. 
We have recently described the response of A/J mice to the phenyltrimethylamino 
(TMA)  hapten,  which  is  characterized  by cross-reactive  idiotype(s)  (CRI)  (CRI- 
TMA).2 An examination of the anti-TMA response for the appearance of the CRI in 
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a  number of strains,  plus the allotype congenic strain C57BL.Ig  e, suggests that  the 
expression  of  the  CRI  is  allotype  linked.  These  findings  made  it  attractive  to 
investigate the possibility that T  cells reactive to the same TMA determinant could 
be modulated by Id antisera used to define anti-TMA antibodies. To this end a helper 
T-cell assay specific  for the  small  synthetic  antigen  L-tyrosine-p-azophenyltrimeth- 
ylammonium [tyr(TMA)] was developed. It was shown in a  preliminary report  (18) 
that both T  and B cells collaborated in a self-help system via TMA determinants on 
a bovine serum albumin (BSA) backbone. In lieu of the tyr(TMA) antigen, Id antisera 
induced TMA-specific T-helper cell activity, which suggested that receptors on T  and 
B cells shared common structural features. 
In this report we describe a system that assays for tyr(TMA) suppressor T  cells that 
interact either directly or indirectly with anti-TMA B cells to produce self suppression. 
Examination of the Id profile in suppressed mice revealed that the suppression of the 
CRI+-TMA was virtually complete, whereas the CRI--TMA clones were left intact. 
A/J mice primed with Id antisera rather than with the tyr(TMA) antigen similarly 
showed a  marked suppression of anti-TMA B-cell formation that was characterized 
by the  complete suppression  of the  CRI+-TMA clones.  These  studies  support  the 
notion  that  T  and  B  cells  interact  via  an  Id  network,  either  directly  or  by  an 
intermediate cell type(s). 
Materials and Methods 
Animals.  Inbred A/J mice of both sexes (The Jackson Laboratory, Bar Harbor, Maine) were 
used throughout these experiments. All mice were 6-9 wk of age when the experiments were 
initiated. 
Antigens.  The  monovalent  antigens  tyr(TMA)  (19) and  L-tyrosine-azobenzenearsonate 
[tyr(ABA)]  (20) and  the  bivalent  antigen  [H-L-tyr(TMA)-NH-(CH2)a]2  (T-S-T)  (15) were 
prepared as previously described.  In some cases tyr(TMA) was prepared commercially (Bio- 
search,  San  Rafael, Calif.)  according to previously described procedures  (19). The hapten- 
protein  conjugate  azophenyltrimethylammonium bovine serum  albumin  (TMA-BSA)  was 
prepared according to the methods of Tabachnick and  Sobatka (21). The conjugate ABA- 
keyhole limpet hemocyanin (KLH) (ABA-KLH) was prepared as described (21); by reacting 1 
g of KLH with  1 mM (0.22 g) of the diazonium salt of trimethylaminoaniline (Baehem,  Inc., 
Torrance, Calif.)  for 3 h,  4°C,  at  pH 9.5. The reaction mixture was exhaustively dialyzed 
against water and then lyophilized.  Twice-crystallized BSA (Sigma Chemical Co., St. Louis, 
Mo.) and KLH (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.) were 
obtained commercially. 
Immunizations.  Both  the small antigens  tyr(TMA)  and  tyr(ABA),  and  the hapten-carrier 
conjugates TMA-BSA and ABA-KLH were emulsified with equal volumes of complete Freund's 
adjuvant  (CFA)  (Difco Laboratories, Detroit, Mich.)  before inoculation.  For soluble  booster 
injections,  the lyophilized antigens were brought into solution with either 0.1 or 1.0 M NaOH, 
neutralized with  HC1, and brought  to the desired  concentration with  Hanks' balanced salt 
solution  (HBSS). Sheep erythrocyte (SRBC) challenge consisted of 0.2 ml of a  10% suspension 
of thrice washed  RBC.  All  other  inoculations  were given intraperitoneally  in  0.1  vol.  (See 
Results  and Figs. 1 and 2 for the various immunization protocols.) 
Irradiation  Transfer Procedures.  Mice  were  given  700  rad  (116-122  rad/min)  whole-body 
irradiation at 80 cm distance with a Gammatron S Colbah 60 therapy unit  (Siemans  Corp., 
Federal Republic of Germany). Irradiated recipients received an adoptive transfer of syngeneic 
cells, 1.0-1.5 X  10  7 T cells and 1.0-1.5 X l0  T  B cells, by retro-orbital injection  usually within 1 
h after irradiation. Recipients were boosted intraperitoneally 16 h after cell transfer with the 
soluble antigen. 
Production, Isolation of Antibody, and Preparation of anti-Id.  Anti-TMA antibody was elicited  in 
A/J mice with the bivalent antigen T-S-T according to the methods of Tung et al. (22). Anti- 530  ANTI-PHENYLTRIMETHYLAMINO  IMMUNITY  IN  MICE 
TMA antibody from a single immune mouse was isolated by affinity chromatography with a 
TMA-Sepharose 4B (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) 
immunoadsorbent prepared according to Cheseboro and Metzger  (23).  After elution of the 
antibody with 10  -3 M tyr(TMA), the protein was exhaustively dialyzed against borate-buffered 
saline. As determined by the OD~0 using the Ei~  "m --- 14, 500 #g oftbe antibody was inoculated 
in CFA into each of several rabbits. Subcutaneous booster injections, with doses ranging from 
100 to 300 #g in CFA, were given periodically and the rabbits were bled  10-20 d  after the 
boost. Antisera from several bleeds were pooled and then adsorbed with normal A/J Ig coupled 
to Sepharose 4B  (24) until the antisera no longer reacted with normal A/J  Ig.  As already 
described,  2 this antiserum showed the following characteristics with respect to Id specificity: (a) 
In an indirect radioimmunoassay (25),  which used ~2  ng of labeled proband antibody, of 
which 30% was bound in the assay,  10-50 ng inhibited significant binding between the Id 
125  antiserum (anti-Id) and the  I-labeled proband antibody. No significant inhibition of this 
reaction was seen when as much as 20 #g of normal A/J mouse Ig or the mouse myeloma 104E 
was added.  (b). This antiserum inhibited anti-TMA plaque-forming cells  (PFC) in A/J mice, 
whereas it did not inhibit anti-ABA or SRBC PFC. 
Normal rabbit serum (NRS) used as a control was absorbed on Sepharose-Ig in an identical 
manner to the anti-Id absorption procedures. Inoculation of mice with either 0.2 ml of anti-Id 
or NRS was given via the retro-orbital plexus. The idiotype binding capacity (IBC)  for this 
absorbed serum was  shown to be  10.7 #g/ml of serum and was  determined by the indirect 
radioimmunoassay using a  fixed  volume of antiserum while varying the  concentration of 
antigen. The IBC value was calculated by extrapolation to infinite antigen concentration. 
Plaque Assays.  Anti-TMA, ABA, and SRBC PFC were determined by a slide modification 
of the Jerne plaque assay  as already described (26). The indicator SRBC, TMA-SRBC, and 
ABA-SRBC  were  prepared  as  follows:  0.5  ml  of packed  and  saline-washed  SRBC  were 
resuspended in 8-10 ml of phosphate-buffered saline (PBS).  To this suspension, 0.12  ml of a 
0.05 M solution of the TMA or ABA diazonium salt was added and allowed to react for 10 min 
at 4°C. The cells were then washed three times with PBS and resuspended to a final 30% vol/ 
vol concentration. Only indirect PFC were scored because no significant direct PFC have ever 
been observed. (See Table I for more details.) 
PFC that produce antibodies bearing the CRI-TMA were determined by incorporating 100 
#1 of Id antisera into the plaquing medium. The percent inhibition of PFC was calculated 
according to the following equation: Percent inhibition =  (1 -  total PFC[anti-Id])/totai PFC, 
in which the total PFC (anti-Id) represented the number of PFC in the presence of anti-Id over 
the number of PFC in the  absence of the antisera. The percent inhibited were judged the 
CRI+-TMA PFC and those remaining were designated the CRI--TMA population. 
Preparation of B Cells.  To eliminate splenic T cells, spleen cell preparations were treated with 
a  rabbit anti-A/J mouse brain serum  prepared  as  described  (27).  2  ml of the  antiserum, 
adsorbed with A/J liver diluted 1:5 in HBSS, were added to 80 X  107 spleen cells in 5-8 ml 
total vol of HBSS, and the cells were incubated at 4°C for 30 min. At this time, guinea pig 
complement (C'), absorbed first with agarose (28) and then with a mixture of A/J liver and 
spleen, was added at a final 1:9 dilution and incubated at 37°C for  1 h. After washing, -50% 
of the original live cells were recovered, of which 90% were Ig  +, as determined by immunoflu- 
orescence witha goat anti-mouse Ig reagent (Meloy Laboratories Inc., Springfield, Va.). 
Preparation of T Cells.  To obtain T  cells, spleen cells were passed over nylon wool columns 
by the method of Julius et al.  (29). Approximately 90% of the column-passed cells were killed 
by the rabbit anti-T-cell serum plus C'. Examination by immunofluorescence indicated that 
90% of the column-passed cells were Ig-. 
Results 
Because very little was known about the immunogenicity of the synthetic antigen 
tyr(TMA) in the mouse species, a protocol was first worked out to assay for suppressor 
T-cell activity. Our rationale was  based on earlier observations that  demonstrated 
that  priming  mice  with  the  monovalent  antigen  tyr(TMA)  for  1  wk  and  then 
challenging with  TMA-BSA  resulted  in  an  enhanced  anti-TMA  PFC  response Y.  G.  ALEVY AND C. J.  BELLONE  531 
Fzc.  1. 
tyr (TMA) I CFA  6weeb  TMA- BSA I CFA  3~b  TMA- BSA I HBSS 
100ugl0.1ml(l.p.)  I  100uglO.lmlli.p.)  1  .501~g/0.1ml(i.p.! 
or 
tyr (ABA) / CFA  I 
100u9 / 0. ]ml (i. p, )  1 week 
or 
CFA alone 
0.1ml (i.p.) 
Spleen Cells 
anti- TMA PFC 
Protocol for determining suppressor  T-cell activity. See Results for detailed explanation. 
TABLE  I 
Pretreatment with tyr(TMA )  Induces Suppression of TMA Plaques 
Antigen  Number of  PFC/IO  s cells ±  SE 
mice 
anti- TMA * 
tyr(TMA)  38  8,761  ±  1,478:]: (66%)§ 
CFA  30  25,513  +  2,201 
tyr(ABA)  8  26,247:1:4,077 
anti-ABAII 
tyr(TMA)  9  1,250¶ ±  149 (13%) 
CFA  6  1,441  ±  310 
anti-SRBC* * 
tyr(TMA)  5  216,200  ± 85,010 (-20%) 
CFA  5  174,000  -4- 31,761 
* See Fig.  1 and text for immunization protocol used to generate anti-TMA 
PFC. 
Differences  between the tyr(TMA) group and the controls,  tyr(ABA),  and 
CFA is significant,  P  <  0.005  (Student's  t  test).  Only indirect  PFC are 
recorded.  All PFC data are expressed as the mean ±  SE. 
§ Numbers in parentheses  are the percent inhibition of PFC in the tyr(TMA) 
group compared with the CFA group. 
II 6 wk after priming with tyr(TMA) in CFA or CFA alone, both groups were 
inoculated with 100 #g ABA-KLH in CFA, boosted  4 wk later with ABA- 
KLH in HBSS, and plaqued 5 d after the final boost. 
¶ The PFC numbers in these groups are significantly above background PFC 
determined by plaquing identical numbers of lymphoid cells against unsub- 
stituted SRBC. Background PFC average 100 PFC/10  s spleen cells. 
** 6 wk after priming with tyr(TMA) in CFA or CFA alone, both groups were 
inoculated with 0.2 ml of a  10% vol/vol SRBC suspension  and plaqued 5 
d later. 
compared  with  non-tyr(TMA)-primed  mice. This  was  shown  to  be  mediated  by  T- 
helper cells collaborating  with  B  cells,  both  specific for the  TMA  determinant.  We 
reasoned  that  if after  1 wk we could demonstrate  a  helper activity, then  priming  for 
longer periods of time may generate suppressor  activity. According, as shown  in Fig. 
1,  mice were  inoculated  with  either  tyr(TMA),  tyr(ABA),  or CFA  alone,  followed 6 
wk  later  by  TMA-BSA  in  CFA,  and  finally boosted  3  wk  later  with  TMA-BSA  in 
solution.  1 wk after the final boost  all animals were plaqued  for anti-TMA  antibody 
formation.  As seen in Table  I, animals primed with monovalent  tyr(TMA)  showed  a 
66%  reduction  in  the  number  of anti-TMA  PFC  compared  with  the  tyr(ABA)-  or 
CFA-primed  groups. 
Specificity  of  the  antigen-induced  suppressor  activity  was  demonstrated  at  the 
afferent limb of this response,  because suppression  of anti-TMA  PFC was noted only 532  ANTI-PHENYLTRIMETHYLAMINO IMMUNITY  IN MICE 
TABLE  II 
Kinetics of Suppression by tyr(TMA) 
Number of  PFC/10  s cells ::1=  SE  Percent in- 
Antigen  mice  hibition 
4 wk 
tyr(TMA)  9  21,688 + 6,160"  41 
CFA  9  36,755 zl: 10,323 
6 wk 
tyr(TMA)  38  8,761 -i- 1,478  66 
CFA  30  25,513 + 2,201 
9 wk 
tyr(TMA)  7  17,014 :t: 4,282  -9 
CFA  7  15,521 :t: 5,128 
12 wk 
tyr(TMA)  7  28,205 + 4,950  -33 
CFA  4  21,840 + 3,179 
After priming with either tyr(TMA) in CFA or CFA alone, animals were 
challenged with TMA-BSA either 4, 6, 9, or 12 wk later to monitor anti- 
TMA suppression. See footnotes to Table I for details. 
* The  differences between  the  tyr(TMA) and  the CFA group  at  4 wk  is 
significant at the P < 0.05 level (Student's t test). 
with tyr(TMA) priming, whereas there was no difference in the anti-TMA response 
between  CFA-  and  tyr(ABA)-primed mice.  Furthermore,  the  suppression  of anti- 
TMA  PFC  by  priming  with  tyr(TMA)  was  specific at  the  efferent  limb,  because 
challenge of tyr(TMA)-primed animals with either ABA-KLH or with SRBC did not 
suppress  the  response to  the ABA hapten  or to  SRBC  when  compared  with  CFA- 
primed animals challenged in an identical manner  (Table I). It should be noted that 
all mice were challenged with the heterologous antigens  1 wk after priming, but the 
immunization  protocols thereafter  were  different  as a  result  of the  kinetics of PFC 
formation  for  these  antigens  (Table  I).  A  possible criticism  of these  heterologous 
antigen controls lies in  the timing and  numbers  of PFC  generated  after challenge. 
Optimal anti-ABA PFC  numbers were  generated  by boosting 6  wk after challenge, 
but it may be argued that suppression was overridden in this 6-wk interval. Thus we 
tried to keep the ABA-KLH protocol similar to the TMA-BSA schedule. The SRBC 
controls resulted in PFC numbers that were approximately eightfold higher than the 
anti-TMA  PFC  response.  It  might  be  argued  that  this  magnitude  of response  can 
override suppression. Nevertheless, the above data indicate that the suppressor activity 
effect is specific for the TMA  determinant. 
The  kinetics  of this  suppressor  activity  were  then  followed  after  priming  with 
tyr(TMA).  After inoculation with  either tyr(TMA)  in CFA or CFA alone, animals 
were challenged with TMA-BSA either 4, 6, 9, or  12 wk later to monitor anti-TMA 
suppression. As seen in Table II, at 4 wk there was, on the average, a  41%  inhibition 
ofanti-TMA PFC, this suppression peaked at 6 wk (66% inhibition), and no detectable 
suppressor activity was detected by the 9th or  12th wk after tyr(TMA) priming. 
To establish which cell, T  or B, was responsible for the suppressed anti-TMA PFC 
response, irradiation transfer experiments were employed. The protocols used in the 
transfer experiments are shown in Fig. 2. To examine the T-cell compartment, animals 
were primed with  tyr(TMA)  in CFA and 6  wk later inoculated with  TMA-BSA  in 
CFA. 3 wk thereafter, T  cells from these mice were prepared by passage of spleen cells Y.  G.  ALEVY  AND  C.  J.  BELLONE 
IRRADIATION  SUPPRESSOR  TRANSFER  PROTOCOL 
(yr (TP,~)  I CFA  t  lyr ITMA) / CFA 
100P910. lml (L p. }  10DUg/~lmltkp,) %  or 
tyr (ABA)  / CFA  I  CFA alone 
100~j I O. lml II. p. )  |  Plaque  6inks  O.lml (I.0. I 
6 ',~eeb 
-  \  CFA alone  ~  antFTf,~ I ffC 
O.lml(I.p.)  J  # 
T,-  ,A,C,A  %, 
100Ug/0.Ill (i.p.)  3 ,a,  eeb  3 vdMb 
l.O- 1.5xl0  lO #  Spleen Cells] 
Fro.  2.  Protocol to monitor either T  or B cells  for suppression of anti-TMA PFC. See Results for 
detailed explanation. 
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TABLE  III 
tyr(TMA) Induces Suppressor T Cells 
Source of 
Number of  PFC/10  s cells ±  SE 
mice 
T  cells  B cells 
tyr(TMA)  CFA  18  1,358 ±  424*  (77%) 
CFA  CFA  12  5,828  ±  1,172 
CFA  tyr(TMA)  8  9,765  ±  2,291 
See  Results and Fig.  2 for immunization schedule and explanation of transfer protocols. 
Only indirect PFC are recorded. All PFC data are expressed as the mean ±  SE. 
* Differences between the TT +  BCFA group and the others is highly significant, P <  0.001 
(Student's t test). 
over nylon wool (designated TT cells),  and, along with  1-1.5  ×  107 BCFA cells, they 
were transferred into lethally irradiated syngeneic recipients. After 24 h the recipients 
were inoculated with 50 #g of soluble TMA-BSA, and  7 d  later their spleens were 
plaqued. To assess the contribution of B cells i  n tyr(TMA)-primed spleen cells, T cells 
were  prepared  from  CFA-primed  donors  (TcrA),  and  B  cells were  prepared  from 
tyr(TMA)-primed spleen cells (BT), and this combination was transferred into irra- 
diated recipients, challenged with soluble TMA-BSA, and plaqued  7 d later. When 
assessing  the  cellular  compartments  (T  or  B)  for  the  suppressive  activity,  either 
protocol was always run in parallel with T and B cells prepared from animals primed 
initially with CFA only, (TcrA  +  BCFA). As seen in Table III, there is a  significant 
suppression  (77%) where tyr(TMA)-primed T  cells were transferred along with the 
BCFA population. The suppression of anti-TMA PFC did not appear to be mediated 
by the BT, because transfer of this population along with TcrA cells did not suppress 
the PFC when compared with the TCFA +  BCVA control. Despite the low number of 
PFC, when calculated by the usual PFC per 106 spleen cells, these were bonafide anti- 
TMA-secreting cells that were determined by plaquing with large numbers of spleen 
cells (1-3 ×  106 spleen cells/slide). They were then calculated by subtracting the total 534  ANTI-PHENYLTRIMETHYLAMINO  IMMUNITY  IN  MICE 
TABLE IV 
Anti-Id Serum Substitutes for tyr(TMA) in Inducing Self-suppression to anti- 
TMA PFC 
Mice injected with  Number of  PFC/10 s cells + SE 
mice 
anti- TMA * 
0.2 ml anti-Id  10  6,897 ± 2,168:~ (62%) 
0.2 ml NRS  8  18,150 ± 4,653 
anti-ABA§ 
0.2 ml anti-Id  8  42,300 ± 8,030 (-7%) 
0.2 ml NRS  9  39,555 ± 8,576 
anti-SRBC]l 
0.2 ml anti-Id  6  281,000 ± 42,419 (12%) 
0.2 ml NRS  6  320,000 ± 38,049 
* Same protocol as in Table I except that 0.2 ml anti-Id and NRS substitute 
for tyr(TMA) and CFA. 
:~ Difference  between the anti-ld and NRS group is significant at the P< 0.001 
level (Student's t test). All PFC are expressed as the mean ± SE. 
§ These mice were given 100 #g of ABA-KLH in CFA 6 wk after priming with 
either anti-Id or NRS followed 5 wk later by 50 p.g of ABA-KLH in HBSS 
and plaqued for anti-ABA PFC 4 d after the final boost. Note that  this 
change from the ABA-KLH immunization scheme given in Table I resulted 
in a 30-fold increase in the PFC number to ABA. 
II Same immunization protocol as described in Table I after priming with anti- 
Id or NRS. 
PFC minus the PFC number in a  nonsubstituted SRBC layer (average of 100 PFC/ 
10s). Furthermore, these anti-TMA PFC were blocked with an Id antiserum that has 
been previously described.  2 It should be noted that anti-TMA PFC numbers generated 
in the intact A/J mice were relatively modest (between 200 and 300 PFC/106 spleen 
cells) when compared with other reported anti-hapten responses in vivo. 
Induction  of tyr(TMA)  Suppressor  Activity  by  Id  Antisera.  Attempts  were  made  to 
stimulate suppressor reactivity with  Id antiserum for  the  following reasons:  (a)  we 
have recently demonstrated CRI on anti-TMA antibodies in A/J mice,  2 and  (b)  Id 
antisera directed against the CRI-TMA can induce T-helper cells in vivo specific for 
the TMA determinant (18). These data made it attractive to explore the possibility 
that  Id  antisera directed  to  the  CRI-TMA  could  induce TMA-specific suppressor 
activity. The characteristics of the Id antiserum used in these experiments have been 
described in Materials and Methods. To stimulate suppressor activity by Id antiserum, 
the basic protocol, as outlined in Fig. 1, was used except that priming with tyr(TMA) 
or CFA only was substituted with anti-Id or (NRS), respectively, As seen in Table IV, 
mice  primed  with  anti-Id  showed  a  62%  decrease  in  the  number of  PFC  when 
compared with NRS controls. Specificity of the anti-Id-induced suppression is also 
shown in Table IV. Groups of mice primed with either anti-Id or NRS were challenged 
6  wk  later  with  either  ABA-KLH  or  SRBC.  The  ABA-KLH-primed mice  were 
boosted with soluble ABA-KLH 5  wk later and their spleens plaqued 4  d  after the 
final boost. Plaquing to SRBC was done 5 d  after a  single SRBC inoculation. There 
were no significant differences in the number of PFC to either the ABA hapten or 
SRBC  when  comparing the  anti-Id and  NRS-primed  animals.  Thus  the  anti-Id 
appeared to mimic the tyr(TMA) antigen insofar as 6 wk after priming there was a 
marked suppressor activity with specificity for the TMA determinant. Y.  G.  ALEVY AND C. J.  BELLONE 
TABLE V 
Antigen and Anti-Id Suppress the Major CRI +- TMA PFC 
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PFC/IO  s cells 4- SE  Percent 
Number  CRI  +- 
Mice primed with  of mice  TMA 
No serum  Anti-Id (100/.tl)  PFC 
tyr(TMA)  21  11,300 + 2,400 (49%)  11,000 + 2,300  3 
CFA  17  21,900 ± 2,270  12,000 ±  1,620  46 
0.2 ml anti-Id  5  29,200 :t: 2,000 (49%)  28,900 ± 4,700  1 
0.2 ml NRS  6  56,800 ±  13,000  26,900 ± 5,500  53 
For immunization schedules refer to Table I. Only indirect anti-TMA PFC are recorded. All PFC data are 
expressed as the mean ± SE. Percent CIRI+-TMA  PFC was calculated as follows: PFC + anti-Id/PFC (no 
serum) × 100. Numbers in parentheses represent the percent inhibition of the tyr(TMA) group as compared 
with the CFA group. 
TABLE VI 
Suppression of CRI + PFC by T Cells 
Source of  PFC/10 s cells ± SE  Number  Percent 
of mice  CRI  + PFC  T Cells  B Cells  No serum  Anti-k[ (100 #1) 
tyr(TMA)  CIFA  6  2,910 ± 983* (56%):]:  2,590 ± 962§  11% 
CFA  CFA  3  6,673 ±  1,147  2,973 ± 70211  55% 
For immunization schedules and transfer protocols refer to Table III. Only indirect anti-TMA PFC are 
recorded. All PFC data are expressed as the mean 4- SE. 
* Differences between the TT +  BcF^ and Tcra +  BcF^ groups is significant at  the  P <  0.025 level 
(Student's t test). 
Numbers in parentheses represent the overall percent suppression. 
§ The differences between the PFC numbers in the presence and absence of anti-Id is not significantly 
different. 
[] The differences  between the PFC numbers in the presence and absence of anti-Id is significant at the P 
< 0.025 level (Student's t test). 
Antigen-  and  Anti-Id-induced  Suppression  Results  in  the  Elimination  of the  CRI+-TMA 
PFC.  Based on the proposed network theory (30)  and the more recent work on Id 
restrictions between collaborating T-helper and antibody-producing  cells (16,  17), we 
investigated the  possibility of whether  these  same  restrictions might  be  operating 
between T-suppressor and B lymphocytes in the antigen-induced  suppressor protocol. 
Because the anti-TMA PFC response is characterized by CRI, comprising ~50% of 
the total PFC response when employing TMA-BSA as the immunogen, this marker 
made  it  possible to  follow the  fate  of this subpopulation as  well as  the  non-CRI- 
bearing clones. Selective elimination of one population over another would indicate 
restrictions among suppressor T-cell (T~) clones and specific antibody-producing  cells. 
The Id profile in both the suppressed and nonsuppressed animals was examined by 
incorporating the Id antiserum into the plaquing medium just before plating. As seen 
in Table V, the response to TMA-BSA resulted in ~50% of the PFC that bears the 
major CRI-TMA in the nonsuppressed groups.  In both the tyr(TMA) and anti-Id- 
primed animals the total PFC response was suppressed by 49% and could be accounted 
for by the almost complete and exclusive elimination of the CRI+-TMA PFC. The 
CRI--TMA PFC were left intact (Table V) when comparing the PFC number in the 
presence and absence of anti-Id in both the tyr(TMA)- and the anti-Id-suppressed 
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To demonstrate that tyr(TMA)-induced "Is cells could mediate the selective elimi- 
nation  of the CRI  ÷ anti-TMA  PFC,  transfer protocols  (as outlined  in  Fig.  2)  were 
employed. As seen in Table VI, the transferred T  cells in this experiment inhibited 
the total anti-TMA  PFC  by 56%,  which  can be accounted  for by the  almost total 
elmination of the CRI  ÷ PFC. 
Discussion 
In  this  report  we have described  an  antigen-specific suppressor system in  which 
both  T  and  B  cells  recognize  the  same  antigenic  determinant,  self suppression. 
Evidence is presented  to show that the monovalent antigen  tyr(TMA)  in A/J mice 
induced a T8 population;  and further, Id antisera directed to the CRI on anti-TMA 
antibodies could stimulate suppressor activity of the same specificity. In either mode 
of induction suppression was highly specific for B-cell clones that bear the major CRI- 
TMA. This was evident when 6-wk tyr(TMA)-primed animals were challenged with 
TMA-BSA in CFA and plaqued after an intervening boost. In nonsuppressed groups, 
challenge with TMA-BSA elicited a response that was comprised of ~50% CRI  + and 
50% CRI- anti-TMA PFC.  Challenge in the tyr(TMA)-primed group resulted  in a 
50%  suppression  of  the  total  anti-TMA  PFC,  which  was  accounted  for  by  the 
elimination of the CRI  + PFC population.  Examination of the remaining 50% of the 
PFC revealed that they were not inhibited by the anti-Id and, therefore, CRI-. These 
data  suggest  the  T8  population  neglected  the  CRI-  B  cells  in  vivo,  and  to  our 
knowledge  this  is  the  first  report  of  a  specific  antigen-induced  T  cell-mediated 
suppression that is Id specific. 
What  might  be the  mechanisms involved in  this  very restricted  Id  suppression? 
Such a mechanism is offered by the network hypothesis (30), which envisions a series 
of regulatory interactions between cells bearing Id determinants, both T  and B, and 
ceils bearing complementary anti-Id receptors. The demonstration of both T  and B 
cells bearing similar idiotypes (12-15)  and the existence of anti-Id clones have been 
reported  (10,  31,  32).  With  respect  to  the  suppressor  system,  this  network  might 
operate  as  follows:  A  first  set  of idiotypes  on  the  surface  of antigen-specific  Ts  is 
stimulated by the antigen. This is followed by a second set of complementary anti-Id 
clones, which in turn act directly on the Id  + B cells or on T-helper cell  (Th) clones, 
assuming the Th cells bear similar idiotypes to the T~, which then cease to deliver the 
appropriate signals to the B  cell and PFC  formation shuts  down.  An alternative to 
this proposed pathway is the possibility that the same T  cell recognizes antigen and 
the idiotype. However, evidence to date would suggest that the former scheme is the 
more likely (11,  33).  In any case, the shut  down of restricted numbers of Id-bearing 
clones would depend upon a restricted number of first-set idiotypes activated. 
To strengthen our contention that the Id network is operating in the TMA system, 
evidence  is  needed  that  both  T  and  B  cells  share  similar,  if  not  identical,  Id 
determinants. To date we do not have conclusive evidence that this is the case but, we 
offer several arguments,  albeit  indirect,  that  TMA receptors on T  and  B  cells may 
share some structural similarity. We have preliminary evidence that the monovalent 
antigen  tyr(TMA)  induces  a  Th population  and further,  Id antisera directed  to the 
CRI  on  anti-TMA  antibodies  could  stimulate  Th  of the  same  specificity  (18).  In 
addition, recent experiments have shown that tyr(TMA)-induced Th can be function- 
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(Y. G. Alevy and C. J. Bellone. Unpublished observation.). In these reported experi- 
ments we have been  able to trigger suppressor  activity with anti-Id in  lieu of the 
antigen, which opens the possibility that Ts bears similar idiotypes along with Th and 
B cells. This evidence is not conclusive. Nevertheless, tyr(TMA) does induce T  cell- 
mediated idiotype-specifie suppression (Tables V and VI) and it could be argued that 
at least some T-cell subpopulation, either an antigen-specific Ts or anti-Id-specific T 
clone, is involved in the Id  + B-cell suppression. We argue against Id  ÷ B cells mediating 
this suppression because we have not been able to trigger suppression with tyr(TMA)- 
primed B cells in transfer protocols. We also have never detected any anti-TMA PFC 
after single or multiple injections with monovalent tyr(TMA) (Y. G. Alevy and C. J. 
Bellone.  Unpublished  data.).  Thus,  anti-TMA  B-cell  clones  do  not  appear  to  be 
activated to a  stage of differentiation or expansion by tyr(TMA) that would allow 
them to mediate suppression or produce detectable amounts of antibody that might 
trigger an anti-Id clone. 
A  somewhat  similar  finding was  reported  by  Benjamin  and  Teale  (34)  using 
tolerogenic doses of arsanilic acid (Ars)  coupled to human gamma globulin (HGG) 
(Ars HGG). In this report it was shown that tolergenic doses followed by immunogenic 
levels  of Ars  HGG  resulted  in  significant  decreases  of total  anti-Ars.  This  was 
accounted for by the selective loss of the major CRI found on anti-Ars antibodies in 
the A/J strain. However, they had no evidence of a idiotype-specific T~ operating in 
this system, although this idea was entertained in their discussion. 
Evidence for idiotype suppression, in which anti-Id is introduced in vivo, has been 
observed in adult mice with small doses of anti-Id (31), in adult mice with large doses 
of anti-Id together with administration of antigen (35), and in newborn mice (36). In 
the first two cases suppression was shown to be mediated by T  cells.  Further, Owen 
et al.  (10) have shown a  T-cell population in the suppressed mouse that binds Id  ÷ 
anti-Ars antibodies and, when isolated, these T  cells mediate idiotype-specific sup- 
pression  (35).  Recent transfer experiments from mice suppressed  to the CRI  (Ars) 
indicate that the cell responsible for the suppression'bears  Ly-2+-3  + antigens (37). 
Thus, the evidence for Id-specific suppression and/or the existence ofT anti-Id clones 
is clear, but whether Id-specific suppression or these anti-Id clones play a role in the 
normal immune response to Ars is unclear. 
Bona  and  Paul  (38) have  recently  demonstrated  naturally  occurring  idiotype- 
specific suppressor T cells directed to the idiotype(s) associated with the trinitrophenol- 
binding mouse myeloma protein MOPC 460. No introduction of antigen and/or anti- 
Id in vivo was necessary to detect their activity. Their results, along with the data in 
the TMA system, support the concept of idiotype-specific T  cells playing a  general 
physiological role in immune regul~ition. 
Support for Id restrictions playing a role in the immune response has recently come 
from two laboratories in which they present evidence for idiotype-specific Th popu- 
lations (16,  17). Woodland and Cantor (16)  have demonstrated that Th specific for 
the Ars idiotype are essential in the expression of Ars-specific B cells bearing the CRI 
(Ars). Surprisingly, they found Id restrictions between KLH-specific Ly-1-helper cells 
and Ars-specific Id  + B cells in this classical carrier-hapten protocol. However, Hetz- 
elberger and Eichmann (17) were unable to show Id preferences between T  and B 
cells that  recognize different determinants on a  carrier-hapten  complex. They did 
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same group A carbohydrate determinant. In both antigen systems, the introduction 
of Id antisera in vivo was necessary to either amplify (17) or block (16) the Id  + T  and 
B clones to detect Id restrictions between these cells types. Our results would indirectly 
support these (16,  17) findings by extending Id restrictions to T~ and B-cell interactions 
induced by antigenic stimulation only. Apparently, our synthetic antigen can dissect 
out these Id-restricted interactions by triggering a  very restricted number of clones, 
possibly all bearing similar or identical Id determinants. 
Is  the  immediate  target  of the  TMA-specific T~  a  Th  that  can  then  no  longer 
collaborate with Id  + B clones or the B cells that  are directly turned off by the Id- 
specific T~ population?  Because we  monitor suppression  by challenge with  TMA- 
BSA, much of the helper activity for the CRI  + and CRI- B cells can be supplied by 
BSA-specific Th populations. Unless BSA activates Id-specific Th, as in the Ars system 
(16), then it is likely that CRI + B cells are the direct target of the T~ population. 
Many questions remain to be answered in this antigen system. Is there an antigen- 
specific Ly-2+-3  +  T8  that  bears  the  CRI-TMA  determinants  that  in  turn  trigger 
idiotype-specific T~? Are both these T~ populations mandatory in suppression of the 
anti-TMA  response,  or  can  an  antigen-specific  Id  +  T~  directly and  preferentially 
interact with  Id  + B  cells? The possibility of two identical receptors complexing to 
mediate  cell-cell  interactions  has  been  suggested  in  other  systems  (39).  We  are 
currently  investigating  these  problems,  as well  as  testing  the  stringency  of these 
apparent Id restrictions by making use of the Id  ÷ C57.Ig  e allotype congenic strain and 
the Id- C57BL/6 partner. 
Despite these unanswered questions, the tyr(TMA) antigen system in mice should 
prove a  valuable  tool  in  dissecting  out  the  physiological  role of idiotypes  in  the 
immune response. 
Summary 
The anti-phenyhrimethylamino (TMA) response in A/J mice is characterized by 
a  cross-reactive idiotype(s)  (CRI)  that  appears  linked  to the  Ig-I  e allotype.  2 These 
findings made it attractive to look for a  CRI on T  cells reactive to the same TMA 
determinant. Thus a suppressor T-cell (Ts) assay specific for L-tyrosine-p-azophenyl- 
trimethylammonium [tyr(TMA)] was developed. 
A/J mice were primed with either tyr(TMA) in complete Freund's adjuvant (CFA), 
L-tyrosine-azobenzenearsonate [tyr(ABA)] in CFA, or with CFA alone. 6 wk later all 
mice were inoculated with TMA-bovine serum albumin (BSA) in CFA, boosted with 
soluble TMA-BSA 3 wk later, and plaqued 7 d after the soluble boost. Priming with 
tyr(TMA)  in  CFA  resulted  in  66%  suppression  of anti-TMA  plaque-forming cells 
(PFC) as compared with control groups primed with tyr(ABA) in CFA or CFA alone. 
The suppression was shown to be mediated by Ts, as only T  cells but not B cells from 
suppressed animals transfer the suppression in adoptive cell transfer experiments into 
lethally irradiated recipients. The profile of the anti-TMA PFC in the suppressed and 
nonsuppressed animals was examined via incorporation ofanti-idiotypic sera (specific 
for CRI-TMA) into the plaquing medium. The results of these experiments indicate 
that the suppression of the major CRI+-TMA PFC was virtually complete, whereas 
the CRI--TMA PFC are left intact. 
When  A/J  mice were primed with  idiotypic antisera  (anti-Id)  or normal  rabbit 
serum (NRS) rather than with the antigen on CFA alone, and the same protocol was Y. G.  ALEVY AND C. J.  BELLONE  539 
followed thereafter,  the anti-Id-inoculated  mice were suppressed  by 63% when com- 
pared with the NRS-primed controls. Again the suppression  could be accounted for 
by the exclusive elimination of CRI  + anti-TMA PFC. 
The  possibility  that  the  antigen-induced  idiotype  suppression  may  result  from 
idiotypic restrictions between interacting CRI+-T8 and CRI÷-B cells will be discussed. 
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